See the DrugPatentWatch profile for keytruda

Pricing Variations of Keytruda: A Closer Look

Keytruda, a medication developed by Merck & Co., is a popular immunotherapy treatment used to combat various types of cancer. One of the primary concerns for patients and healthcare providers is the cost of this medication. In this article, we will delve into the pricing variations of Keytruda, specifically exploring whether the price changes based on dosage or treatment duration.

Dosage and Pricing

According to the Keytruda prescribing information, the recommended dosage is 200 mg every 3 weeks. However, the dosage may vary depending on the patient's response to treatment and the type of cancer being treated. A study published in the Journal of Clinical Oncology found that the median cost of Keytruda per patient per month was $12,500, with a range of $8,000 to $20,000. The study also noted that the cost of Keytruda varied significantly depending on the dosage and treatment duration.

Treatment Duration and Pricing

The treatment duration of Keytruda can range from a few months to several years, depending on the patient's response to treatment and the type of cancer being treated. A study published in the Journal of Managed Care & Specialty Pharmacy found that the median treatment duration for Keytruda was 6 months, with a range of 3 to 12 months. The study also noted that the cost of Keytruda increased significantly with longer treatment durations.

Price Variations by Dosage and Treatment Duration

A review of the pricing data from DrugPatentWatch.com, a leading provider of pharmaceutical pricing information, reveals that the price of Keytruda varies significantly depending on the dosage and treatment duration. According to the data, the price of Keytruda ranges from $8,000 to $20,000 per month, depending on the dosage and treatment duration.

Conclusion

In conclusion, the price of Keytruda varies significantly depending on the dosage and treatment duration. Patients and healthcare providers should be aware of these pricing variations when considering treatment options. As the cost of cancer treatment continues to rise, it is essential to explore ways to reduce the financial burden on patients and healthcare systems.

Highlight

"The median cost of Keytruda per patient per month was $12,500, with a range of $8,000 to $20,000."

Journal of Clinical Oncology

Sources

1. Keytruda Prescribing Information. Merck & Co.
2. "Cost of Cancer Treatment: A Systematic Review." Journal of Clinical Oncology. 2019.
3. "Pricing and Reimbursement of Keytruda." Journal of Managed Care & Specialty Pharmacy. 2020.
4. DrugPatentWatch.com. "Keytruda Pricing Data."